莱古马因缺乏症通过调节T细胞受体信号传递来阻止动脉动脉生成
Xuying Xiang1, Feng Zhang1, Lei Nie1
1Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Aging cell
|October 30, 2024
概括
在小鼠中,木素缺乏会减少CD4+T细胞的积累和动脉样硬化进展. 这表明,木素抑制可以通过影响T细胞功能来作为动脉样硬化的一种新疗法.
科学领域:
- 心血管生物学 心血管生物学
- 免疫学 免疫学 免疫学
- 分子医学是分子医学.
背景情况:
- 动脉样硬化是一种与年龄相关的疾病,与斑块和血中的豆类蛋白增加有关.
- 莱古马因在动脉样硬化病原体中的确切作用尚未完全理解.
研究的目的:
- 为了研究豆在动脉样硬化斑块进展中的作用.
- 检查木素对CD4+T细胞功能和动脉样硬化的表型的影响.
主要方法:
- 生成的豆类素缺乏的阿波利波蛋白E缺乏 (Lgmn-/-Apoe-/-) 的小鼠.
- 分析了CD4+ T细胞积累,病变大小和T细胞受体信号通路.
- 进行了转录基因分析,以评估T细胞分化,生存和功能.
主要成果:
- 莱古马因缺乏减弱了CD4+ T细胞在斑块中的沉积,并减少了动脉样硬化病变.
- 勒古马因的删除降低了血液,淋巴结和脏中的CD4+T细胞水平.
- 莱古马因缺乏抑制了CD4+记忆T细胞分化,存活和通过T细胞受体信号传递的功能,减少IL-2和IFN-γ的释放.
结论:
- 莱古马因缺乏会影响CD4+T细胞的存活,增殖和功能,导致动脉样硬化减少.
- 豆类蛋白在动脉样硬化斑块的发展中起着至关重要的作用.
- 抑制木素活性为动脉样硬化治疗提供了潜在的治疗策略.
相关概念视频
T Cell Types and Functions
955
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
955
Intracellular Signaling Affects Focal Adhesions
2.6K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.6K
Role Of Notch Signalling In Intestinal Stem Cell Renewal
2.1K
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.1K
Inflammatory Response
1.9K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
1.9K
TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
Myasthenia Gravis: Overview and Treatment
1.2K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.2K


